Skip to main content
. 2022 Dec 5;11:149. doi: 10.1186/s13756-022-01183-y

Table 2.

In vitro efficacy of aHP for the preselected set of micro-organisms, expressed in log-reduction

Micro-organism Effect in log10 reduction, median (range) N (ref)
Viruses

Norovirus

(Surrogate)

2.5 (0.5–2.7)

4.5 (> 4–5.3)

3 [12, 18, 19]

3 [1820]

Bacteria Acinetobacter 2 (1–>4) 2 [12, 16]
CPE
VRE 1–1.7 1 [21]
ESBL > 6 1 [14]
MRSA > 4 (2–>6) 4 [12, 14, 16, 17]
Spores C. difficile 4.9 (0.13–>5) 4 [12, 14, 22, 23]
Yeast C. auris